Cyndeo Wealth Partners LLC Acquires 1,462 Shares of Intuitive Surgical, Inc. $ISRG

Cyndeo Wealth Partners LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,458 shares of the medical equipment provider’s stock after purchasing an additional 1,462 shares during the period. Cyndeo Wealth Partners LLC’s holdings in Intuitive Surgical were worth $4,790,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in ISRG. Brighton Jones LLC lifted its position in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares during the period. Sivia Capital Partners LLC grew its holdings in shares of Intuitive Surgical by 3.8% during the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after purchasing an additional 34 shares in the last quarter. Schnieders Capital Management LLC. increased its position in shares of Intuitive Surgical by 38.0% in the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after purchasing an additional 268 shares during the period. Dynamic Technology Lab Private Ltd bought a new position in shares of Intuitive Surgical in the second quarter worth $394,000. Finally, Hillsdale Investment Management Inc. raised its stake in Intuitive Surgical by 296.3% in the second quarter. Hillsdale Investment Management Inc. now owns 2,929 shares of the medical equipment provider’s stock valued at $1,592,000 after purchasing an additional 2,190 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Fundamentals remain strong — Intuitive reported an earnings beat and double‑digit revenue growth in its latest quarter, supporting the company’s long‑term growth thesis and valuation premium. Bull of the Day: Intuitive Surgical (ISRG)
• Positive Sentiment: Prominent bullish mentions — coverage including a “Bull of the Day” piece and a Jim Cramer mention keep ISRG on the buy/hold radar for growth investors, which can support buying interest after negative headlines. Jim Cramer Analyzed 5 Stocks
• Neutral Sentiment: Comparative analyses and sector commentary (head‑to‑head pieces) provide context but no immediate catalyst; these may influence longer‑term positioning rather than intraday moves. Head‑To‑Head Analysis: Lombard Medical & Intuitive Surgical
• Negative Sentiment: FDA safety flag on stapler devices — regulators have flagged safety concerns and advised halting affected devices, which is a near‑term operational and reputational risk that likely pressured the stock. FDA Flags Safety Concern Over Intuitive Surgical Stapler
• Negative Sentiment: Company warning and reported death related to stapler reloads — Intuitive issued warnings after at least one reported death, increasing legal, recall and adoption‑risk concerns for affected products. Intuitive warns on surgical stapler reloads with one death reported
• Negative Sentiment: Broader quality and cybersecurity scrutiny — reporting highlights recalls and other operational snags (including cyber incidents), which amplify investor uncertainty about near‑term execution and regulatory exposure. From Cyber Criminals to Recalls: Inside Intuitive Surgical’s Newest Snag
• Negative Sentiment: Technical weakness — the stock recently formed a “death cross” (50‑day moving average crossing below the 200‑day), which can trigger momentum selling from technical traders even if fundamentals remain solid. Intuitive Surgical Stock Just Flashed A Death Cross

Insider Activity at Intuitive Surgical

In other news, SVP Mark Brosius sold 645 shares of the stock in a transaction on Monday, March 9th. The stock was sold at an average price of $485.01, for a total value of $312,831.45. Following the completion of the transaction, the senior vice president directly owned 1,613 shares in the company, valued at approximately $782,321.13. This represents a 28.57% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 105 shares of the firm’s stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 32,943 shares of company stock worth $17,279,568. Corporate insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the subject of several recent analyst reports. Argus cut their price objective on shares of Intuitive Surgical from $630.00 to $560.00 and set a “buy” rating for the company in a research report on Wednesday, February 4th. Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 19th. Raymond James Financial upped their price target on shares of Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a report on Friday, January 23rd. Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target on the stock in a research report on Wednesday, March 11th. Finally, Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $614.95.

Intuitive Surgical Trading Down 0.5%

Shares of NASDAQ ISRG opened at $477.76 on Friday. The company has a market cap of $169.67 billion, a price-to-earnings ratio of 60.55, a PEG ratio of 3.69 and a beta of 1.66. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $603.88. The stock has a 50-day moving average price of $502.83 and a two-hundred day moving average price of $512.95.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The firm’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same period last year, the company posted $2.21 EPS. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.